OSU-03012

OSU-03012 (AR-12) is a celecoxib derivative with anticancer and anti-microbial activity.

Uses your system voice; voice and rate in settings.

≈ 2 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

OSU-03012 (AR-12) is a celecoxib derivative with anticancer and anti-microbial activity. Unlike celecoxib, OSU-03012 does not inhibit COX, but inhibits several other important enzymes instead which may be useful in the treatment of some forms of cancer.

When combined with PDE5 inhibitors such as sildenafil or tadalafil, OSU-03012 was found to show enhanced anti-tumour effects in cell culture. OSU-03012 has been shown to inhibit completely vaccinia virus in cell based assay.

Antimicrobial agent

Antifungal activity against Candida albicans, non-albicans Candida spp., Cryptococcus neoformans, Blastomyces dermatitidis, Histoplasma, and Coccidioides via disruption of phosphoinositide-dependent kinase-1 and inhibition of acetyl—CoA synthetase activity. Activity was enhanced with fluconazole co-delivery. Antiparasitic activity against Leishmania donovani.

Antibacterial activity against Salmonella enterica, and Francisella tularensis. OSU-03012 has also illustrated sensitization of intracellular Salmonella enterica to aminoglycosides. Antiviral when combined with PDE5 inhibitors such as sildenafil or tadalafil against a wide variety of organisms including Lassa virus, Marburg virus, and Ebola virus.

This activity thought to be mediated via inhibition of the chaperone protein BiP. Antimicrobial activity is often not against the microbe directly (like conventional antibiotics), but rather host-directed activity that works on the cellular host to disrupt the pathogen within the cell.

Since the median lethal dose (LD 50 ), in vitro, against macrophages is ~7 μM and near its effective concentration (EC50) formulation of the compound has been shown to enhances its activity. For example, encapsulation of OSU-03012 into biodegradable polymeric (Acetalated dextran) micro/nanoparticles significantly reduces cytotoxicity, increases drug concentration per a cell, reduces toxicity in vivo, and facilitates needle-free delivery in vivo.

Orphan drug designation

The European Commission has designated OSU-03012 as an orphan drug for use in combination with other drugs for treatment of two infections diseases, cryptococcosis and tularaemia. OSU-03012 received an orphan drug designation in combination with the antifungal drug fluconazole for cryptococcosis of the brain. It also received this designation for tularaemia in combination with the antibacterial drug gentamicin.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1370487207 under CC BY-SA 4.0; modifications have been made.

Words in each sectionAntimicrobial agentAntimicrobial agentAntimicrobial agent: 186 words186Orphan drug designationOrphan drug designationOrphan drug designation: 79 words79
Words in each section. Measured from the stored article body; sections below the minimum are not plotted.

Provenance

snapshot enwiki-001370487207 · captured 2026-08-21 · ledger · version history

Cite this page as: encyclopegia.org, “OSU-03012”, snapshot enwiki-001370487207. https://encyclopegia.org/a/osu-03012

Sources cited in this revision

3 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.